UK sports-nutrition firm Applied Nutrition has said the company expects its revenue for its 2025 and 2026 fiscal years to be “ahead of market expectations”.

In a trading update yesterday (19 August), the maker of protein powders, bars and nutrition drinks provided a provisional estimate of its earnings for its financial year that recently closed on 31 July.

Applied Nutrition anticipates revenue to have increased by 24% to £107m ($144.4m). The figure exceeds market forecasts of £100m.

The company attributed the growth to “strong” trading in the second half of the year, which contributed around £60m to its revenue.

Adjusted earnings before interest, tax, depreciation, and amortisation (EBITDA) are projected to rise by 19% from £26m in the prior year.

Additionally, net cash is expected to reach £18.5m, surpassing the market consensus of £16.6m.

The company, which went public in October, credited its performance to the continued execution of its “multi-pillar, global growth strategy”.

Looking ahead, Applied Nutrition expects revenue for the financial year ending 31 July 2026 to also surpass market expectations.

The board expressed confidence in the company’s B2B-focused business model, stating that its core strengths will “continue to drive sustained revenue growth and strong profitability over the long-term”.

Applied Nutrition plans to release its audited results for the year ended 31 July on or around 10 November.

Thomas Ryder, the CEO of Applied Nutrition, said: "We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations."

Applied Nutrition offers four product ranges – Applied Nutrition, ABE, BodyFuel and Endurance – with over 100 products sold in more than 85 countries.

The company operates a US division to support sales through retailer Walmart. It has marketing tie-ups with English and Scottish football clubs, professional boxers and MMA athletes.